Everyone is looking for a nice safe haven in these dark and turbulent times. And what could be safer than a pharmaceutical giant.

Especially one that turns over more cash than most medium-sized countries. After all, whatever happens we will still get ill.

But wait. Perhaps one traditionally safe share has been oversold in recent times and might be looking good for a morsel of money.

Research: GSK.L

Help spread the word - email this episode to a friend Help spread the word - email this episode to a friend